Coxsackie

Coxsackie

Coxsackie refers to a group of viruses that belong to the genus Enterovirus in the family Picornaviridae. These viruses are named after the town of Coxsackie, New York, where they were first isolated. Coxsackie viruses are divided into two groups: Coxsackie A and Coxsackie B, each associated with different clinical manifestations.

Virology

Coxsackie viruses are small, non-enveloped viruses with a single-stranded RNA genome. They are part of the enterovirus subgroup, which also includes Poliovirus and Echovirus. The genome of Coxsackie viruses encodes a single polyprotein that is cleaved into functional viral proteins.

Classification

Coxsackie viruses are classified into two main groups:

• Coxsackie A viruses: These are associated primarily with diseases involving vesicular lesions, such as hand, foot, and mouth disease and herpangina.
• Coxsackie B viruses: These are more often associated with systemic diseases, including myocarditis, pericarditis, and pleurodynia.

Transmission

Coxsackie viruses are transmitted primarily via the fecal-oral route, but they can also spread through respiratory droplets and contact with contaminated surfaces. The viruses are highly contagious, especially in settings such as schools and daycare centers.

Clinical Manifestations

Coxsackie A

• Hand, foot, and mouth disease: Characterized by fever, sore throat, and a rash with vesicles on the hands, feet, and mouth.
• Herpangina: Presents with fever, sore throat, and vesicular lesions on the soft palate and uvula.

Coxsackie B

• Myocarditis and pericarditis: Inflammation of the heart muscle and surrounding sac, respectively, which can lead to chest pain, arrhythmias, and heart failure.
• Pleurodynia (Bornholm disease): Sudden onset of severe chest or abdominal pain, often accompanied by fever and malaise.

Diagnosis

Diagnosis of Coxsackie virus infections is typically based on clinical presentation. Laboratory confirmation can be achieved through:

• Viral culture: Isolation of the virus from throat swabs, stool samples, or cerebrospinal fluid.
• PCR (Polymerase Chain Reaction): Detection of viral RNA in clinical specimens.
• Serology: Detection of specific antibodies against Coxsackie viruses.

Treatment

There is no specific antiviral treatment for Coxsackie virus infections. Management is primarily supportive, focusing on relieving symptoms such as fever and pain. In severe cases, such as myocarditis, hospitalization and more intensive care may be required.

Prevention

Preventive measures include good hygiene practices, such as regular handwashing and disinfection of contaminated surfaces. There are currently no vaccines available for Coxsackie viruses.

Also see

• Enterovirus
• Hand, foot, and mouth disease
• Myocarditis
• Picornaviridae